Lupus pericarditis: chest pain and fever amidst COVID19 pandemic

Authors

DOI:

https://doi.org/10.32385/rpmgf.v38i3.13221

Keywords:

Systemic lupus erythematosus, Chest pain, Fever, Cough, Dyspnea, Lupus pericarditis

Abstract

Introduction: Systemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease of unknown cause with multisystemic involvement. In Portugal, it is estimated that 0.07% of the population has this diagnosis, with the first symptoms manifesting in the age group of 16 to 49 years old in 75% of the cases. The clinical manifestations of SLE are multiple and are related to the multisystemic character of this pathology. The heterogeneity of the clinical presentation extends from mild mucocutaneous or joint changes (90%) to impaired renal, pulmonary, cardiac, hematological, or neuropsychiatric function.

Case description: Woman, 18 years old, with a history of SLE, went to an open consultation at her family doctor due to complaints of insidious onset of sternal thoracalgia, aggravated by deep inspiration and relief with anterior flexion of the chest, with the notion of dyspnea, irritating cough, and associated fever.

Comment: SLE due to its multisystemic and chronic nature, is responsible for a wide range of clinical manifestations, being considered by many ‘one of the greatest imitators’. In the current epidemiological context, the presence of symptoms such as fever, chest pain, and cough immediately suggest the diagnostic hypothesis of the disease COVID-19, which, undoubtedly, should be excluded. However, the role of the family doctor, as a privileged expert on the patient’s personal history, namely on their chronic illnesses and their follow-up, as well as on the clinical manifestations associated with the disease’s recurrence or exacerbation, allows him to have a supported diagnostic suspicion.

Downloads

Download data is not yet available.

Author Biography

  • Gustavo Gonçalves Costa, USF Tondela

    Interno Formação Específica em MGF

References

Jiménez S, Cervera R, Font J, Ingelmo M. The epidemiology of systemic lupus erythematosus. Clin Rev Allergy Immunol. 2003;25(1):3-12.

Sociedade Portuguesa de Reumatologia. Lúpus eritematoso sistémico [homepage]. Lisboa: SPR; 2020. Available from: https://spreumatologia.pt/lupus-eritematoso-sistemico/

Miner JJ, Kim AH. Cardiac manifestations of systemic lupus erythematosus. Rheum Dis Clin North Am. 2014;40(1):51-60.

Man BL, Mok CC. Serositis related to systemic lupus erythematosus: prevalence and outcome. Lupus. 2005;14(10):822-6.

Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus. 2005;14(9):683-6.

Chiabrando JG, Bonaventura A, Vecchié A, Wohlford GF, Mauro AG, Jordan JH, et al. Management of acute and recurrent pericarditis: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(1):76-92.

Zayas R, Anguita M, Torres F, Giménez D, Bergillos F, Ruiz M, et al. Incidence of specific etiology and role of methods for specific etiologic diagnosis of primary acute pericarditis. Am J Cardiol. 1995;75(5):378-82.

Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26(9):965-1012.e15.

Imazio M, Pivetta E, Restrepo SP, Sormani P, Pedrotti P, Quarta G, et al. Usefulness of cardiac magnetic resonance for recurrent pericarditis. Am J Cardiol. 2020;125(1):146-51.

Muangchan C, van Vollenhoven RF, Bernatsky SR, Smith CD, Hudson M, Inanç M, et al. Treatment algorithms in systemic lupus erythematosus. Arthritis Care Res. 2015;67(9):1237-45.

Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725.

Rooney J. Lupus eritematoso sistémico: el gran imitador desenmascarado. Nurs (Ed española). 2006;24(10):32-8.

Gladman DD, Ibañez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29(2):288-91.

Pacheco D, Alvarez ME, Vizcarra G, Fuentealba C, Marinovic MA, Ballesteros F. Características de la hospitalización reumatológica en un hospital de nivel terciario [Features of patients with rheumatic diseases admitted to a tertiary care hospital]. Rev Med Chil. 2001;129(6):653-9. Spanish

Petri M, Genovese M. Incidence of and risk factors for hospitalizations in systemic lupus erythematosus: a prospective study of the Hopkins Lupus Cohort. J Rheumatol. 1992;19(10):1559-65.

Published

2022-07-07

How to Cite

Lupus pericarditis: chest pain and fever amidst COVID19 pandemic. (2022). Portuguese Journal of Family Medicine and General Practice, 38(3), 300-4. https://doi.org/10.32385/rpmgf.v38i3.13221